4CPS-193 Effectiveness and safety of intravenous ustekinumab intensification in Crohn’s disease with loss of response or partial response to subcutaneous therapy
S. Herrero Bermejo, E. Lobato Matilla, D. Gómez Costas, B. Somoza Fernández, P. Ruíz Briones, M. Ferris Villanueva, Mdp Montero Antón, Y. Rioja Díez, A. Carrillo Burdallo, A. Herranz Alonso, M. Sanjurjo Sáez
{"title":"4CPS-193 Effectiveness and safety of intravenous ustekinumab intensification in Crohn’s disease with loss of response or partial response to subcutaneous therapy","authors":"S. Herrero Bermejo, E. Lobato Matilla, D. Gómez Costas, B. Somoza Fernández, P. Ruíz Briones, M. Ferris Villanueva, Mdp Montero Antón, Y. Rioja Díez, A. Carrillo Burdallo, A. Herranz Alonso, M. Sanjurjo Sáez","doi":"10.1136/ejhpharm-2024-eahp.297","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":121840,"journal":{"name":"Section 4: Clinical pharmacy services","volume":"38 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 4: Clinical pharmacy services","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-eahp.297","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
